ERGE Refractario a IBP: Tratamiento Endoscópico | October 2021-Webinar Recording

Video Transcription

Video Summary

Welcome to the ASGE Global Spotlight webinar series. This particular webinar is titled "Refractory Gastroesophageal Reflux Disease to Proton Pump Inhibitors: The Endoscopic Treatment." The presentation is given by Dr. Oscar Hernandez Mondragon, the head of the Department of Endoscopy at the Hospital de Especialidades, Centro Medico Nacional Siglo XXI, IMSS, Mexico City. The webinar discusses the definition, prevalence, clinical implications, and pathophysiology of gastroesophageal reflux disease (GERD), as well as its medical and surgical treatments. Dr. Mondragon also presents various endoscopic treatment options for refractory GERD, including the Estreta device, mucosal volume reduction techniques, hybrid therapy, and transoral incisionless fundoplication (TIF) using the EsophyX system. He discusses the advantages and limitations of each method, along with their efficacy and safety profiles. Additionally, Dr. Mondragon mentions the use of hybrid therapy after peroral endoscopic myotomy (POEM) in patients with reflux symptoms. The webinar concludes with a discussion on the management of barreled esophagus and the potential for future research in the field. The presentation is followed by a question and answer session.

Keywords

Refractory Gastroesophageal Reflux Disease

Proton Pump Inhibitors

Endoscopic Treatment

Dr. Oscar Hernandez Mondragon

GERD

Estreta device

Transoral incisionless fundoplication

EsophyX system

Hybrid therapy